Hermetica Superfood Encyclopedia
The Short Answer
Tetraselmis suecica contains chlorophylls (chlorophyll a: ~1.69 mg/g DW), carotenoids (~5.38 µg/g DW), phenolic compounds (~28.03 mg GAE/g DW), and low-molecular-weight antimicrobial peptides that collectively drive potent free-radical scavenging and membrane-disrupting antibacterial activity. In vitro DPPH radical scavenging assays on acetone extracts return an IC50 of 37.32–38.26 ppm, a threshold classified as 'very strong' antioxidant activity, while purified peptide fractions (<10 kDa) achieve 96% killing of Escherichia coli at 0.5 µg/µL.
CategoryOther
GroupMarine-Derived
Evidence LevelPreliminary
Primary KeywordTetraselmis suecica benefits
Tetraselmis suecica — botanical close-up
Health Benefits
**Potent Antioxidant Activity**
Chlorophyll a, chlorophyll b, and carotenoids in acetone extracts donate electrons or hydrogen atoms to neutralize reactive oxygen species, yielding a DPPH IC50 of 37–38 ppm—well below the 50 ppm threshold defining 'very strong' antioxidant capacity in this assay.
**Broad-Spectrum Antibacterial Action**
Acid-extracted, C-18-purified peptide fractions (<10 kDa, 40% acetonitrile elution) disrupt both Gram-negative (E. coli) and Gram-positive bacterial membranes, achieving 96% bactericidal efficacy at 0.5 µg/µL in survival assays.
**High Phenolic Content Supporting Cellular Protection**: A phenolic load of 28
03 mg gallic acid equivalents per gram dry weight confers secondary antioxidant and potential anti-inflammatory capacity, as phenolics can chelate transition metals and quench lipid peroxidation chain reactions.
**Micronutrient Density Relevant to Anti-Aging**
The alga contains vitamins A, B1 (thiamine), B2 (riboflavin), B3 (niacin), and D2, alongside tocopherols (vitamin E forms including α-tocopherol), providing cofactors essential for mitochondrial energy metabolism and skin-cell maintenance, though precise concentrations in standardized extracts remain unpublished.
**Aquaculture-Validated Nutritional Utility**: Dietary inclusion of T
suecica improves growth performance and nutrient utilization efficiency in multiple finfish species, demonstrating that its nutrient matrix is biologically available at the organismal level, even if direct human evidence is lacking.
**Functional Gelling and Structural Bioactivity**
Extracts display viscoelastic gel-forming properties (storage modulus G′max up to ~723–2430 Pa), suggesting potential as a bioactive matrix or delivery vehicle for encapsulating antioxidant compounds in nutraceutical formulations.
**Potential Prebiotic and Immune-Modulating Properties**
Like related green microalgae, T. suecica's cell-wall polysaccharides (sulfated galactans and cellulose) may modulate gut microbiota composition and stimulate innate immune signaling pathways, though direct evidence for this species specifically is preliminary.
Origin & History
Natural habitat
Tetraselmis suecica is a unicellular green microalga (class Chlorodendrophyceae) native to marine and brackish coastal waters across temperate and subtropical regions worldwide, including European Atlantic coastlines and the Mediterranean Sea. It thrives in photic zones under moderate salinity (25–35 ppt), temperatures of 15–25°C, and high light availability, making it amenable to controlled photobioreactor and open raceway pond cultivation. It has been commercially cultivated primarily as a live feed in aquaculture hatcheries for bivalves, crustaceans, and finfish larvae since the mid-20th century.
“Tetraselmis suecica has no documented history of use in any traditional medicine system—Ayurvedic, Traditional Chinese Medicine, indigenous Pacific, or otherwise—and does not appear in pre-modern pharmacopeias or ethnobotanical records. Its documented human-adjacent use began in the mid-20th century as a live phytoplankton feed in European marine aquaculture hatcheries, where it was selected for its robust growth, high lipid content, and palatability to bivalve and crustacean larvae. Scientific interest in its bioactive compounds for human health applications emerged only in the 2000s and 2010s alongside broader research into marine microalgae as sources of novel antioxidants, antimicrobials, and nutraceuticals. It carries no common vernacular name in any cultural tradition, reflecting its origin as a biotechnology and aquaculture organism rather than a folk remedy.”Traditional Medicine
Scientific Research
The current evidence base for T. suecica in health applications consists exclusively of in vitro biochemical assays and one aquaculture feeding study; no human clinical trials, rodent pharmacological studies, or toxicological assessments have been published. In vitro antioxidant data (DPPH IC50 37–38 ppm) and antibacterial survival assays (96% E. coli killing at 0.5 µg/µL) are replicated across at least two independent extraction methodologies, lending internal consistency, but the absence of cell-culture cytotoxicity data, animal models, and pharmacokinetic profiling means translation to human efficacy cannot be assumed. The aquaculture study demonstrating improved fish growth metrics at high T. suecica dietary inclusion provides proof-of-concept for bioavailability of its nutrient matrix in vertebrates, but the experimental design, species differences, and lack of published effect sizes limit extrapolation. Overall, the evidence base is early-stage and preclinical; conclusions about human anti-aging, antioxidant, or antimicrobial benefits require prospective clinical investigation.
Preparation & Dosage
Traditional preparation
**Acetone Crude Extract (Research Grade)**
30 g dried biomass with acetone, yielding ~1
Produced by extracting ~.9 g deep-green paste (6.33% yield); no established human dose—used only in vitro at concentrations achieving IC50 ~37–38 ppm in DPPH assays.
**Acid Extract + C-18 Peptide Fraction**
Biomass subjected to acid hydrolysis, desalted via ultrafiltration, then fractionated by C-18 reverse-phase chromatography using a 5–100% acetonitrile gradient; the 40% ACN fraction contains the active <10 kDa antimicrobial peptides effective at 0.5 µg/µL in vitro—no human dosing established.
**Aquaculture Live-Feed or Dried Paste**
Commercially available as concentrated live algal paste or spray-dried powder for aquaculture use at inclusion levels typically 5–20% of larval diet; this formulation is not standardized or evaluated for human supplementation.
**Potential Nutraceutical Powder**
Spray-dried whole biomass retains chlorophylls, carotenoids, and vitamins, but no standardized extract, certificate of analysis benchmarks, or human dose ranges have been published for this species specifically.
**Timing and Standardization Note**
No timing recommendations, standardization percentages (e.g., % chlorophyll, % tocopherol), or clinically validated dose ranges exist for human use; any formulation would require pharmacokinetic study before safe dosing guidance can be issued.
Nutritional Profile
Tetraselmis suecica contains chlorophyll a (~1.69 mg/g DW) and chlorophyll b (~0.71 mg/g DW) as primary photosynthetic pigments, with total carotenoids at ~5.38 µg/g DW including β-carotene and lutein-like xanthophylls. Phenolic compounds reach 28.03 mg GAE/g DW, and the alga is reported to contain vitamins A (as β-carotene precursor), B1, B2, B3, D2, and tocopherols including α-tocopherol, though per-gram concentrations in standardized dried biomass have not been systematically tabulated for this species. Protein content is substantial (characteristic of green microalgae at 20–35% DW in related Tetraselmis spp.), with the acid-extracted peptide fraction showing high protein signal by Lowry or Bradford assay; fatty acids include polyunsaturated forms (EPA and DHA precursors are present in marine green microalgae of this genus at varying levels). Bioavailability of all components in humans is entirely uncharacterized: cell-wall integrity, processing method (live vs. dried vs. extracted), and gut enzymatic capacity to breach algal cell walls are key factors that remain unstudied for T. suecica specifically.
How It Works
Mechanism of Action
The primary antioxidant mechanism involves chlorophyll a and chlorophyll b acting as electron donors within their porphyrin ring systems, transferring hydrogen atoms to DPPH and other free radicals to yield stable, non-reactive products; carotenoids complement this by quenching singlet oxygen and interrupting lipid peroxidation chain reactions through physical energy transfer. Phenolic compounds (28.03 mg GAE/g DW) contribute additional radical neutralization via ortho-dihydroxyl group electron donation and metal chelation, reducing Fenton-reaction-generated hydroxyl radical production. Antimicrobial peptides isolated in the <10 kDa fraction (40% ACN eluate) are proposed to act through cationic amphipathic interactions with anionic bacterial lipopolysaccharide or phosphatidylglycerol membranes, forming transient pores or inducing membrane depolarization selectively in prokaryotic cells. Tocopherols (including α-tocopherol) embedded in cell membranes interrupt lipid peroxidation by scavenging peroxyl radicals and regenerating reduced glutathione-dependent antioxidant cycles, a mechanism directly relevant to the proposed anti-aging application.
Clinical Evidence
No human or animal pharmacological clinical trials have been conducted on T. suecica as a nutritional supplement or therapeutic agent as of the available literature. The totality of controlled evidence comprises in vitro DPPH radical scavenging assays (IC50 37–38 ppm), in vitro bacterial survival assays (96% E. coli reduction at 0.5 µg/µL), and rheological characterization of extract gels. One aquaculture feeding trial demonstrated improved growth and feed conversion in fish, but lacked the controlled design, statistical reporting, and human relevance required to inform supplemental dosing or efficacy claims. Confidence in claimed health benefits for human use is therefore very low, and all bioactivity data should be treated as hypothesis-generating rather than clinically actionable.
Safety & Interactions
No human safety data—including adverse event reports, maximum tolerated doses, or drug interaction studies—have been published for Tetraselmis suecica in any form; its safety profile is entirely unestablished for human supplemental use. In vitro evidence suggests low cytotoxicity at bactericidal peptide concentrations (0.5 µg/µL) and antioxidant activity mediated without apparent cell damage, but in vitro tolerability does not substitute for in vivo toxicology. Individuals with shellfish or seafood allergies should exercise caution, as marine microalgae can carry cross-reactive allergens, heavy metal bioaccumulates (arsenic, cadmium, lead), and marine biotoxins depending on cultivation water quality and harvesting conditions. Pregnancy, lactation, pediatric use, and concurrent use with anticoagulants (vitamin K content in chlorophyll-rich algae), immunosuppressants, or antibiotics (due to its own antibacterial activity) should be approached with extreme caution and ideally deferred until clinical safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Tetraselmis suecica (Kylin) ButcherPlatymonas suecicagreen microalga T. suecicamarine green flagellate
Frequently Asked Questions
What are the main bioactive compounds in Tetraselmis suecica?
Tetraselmis suecica contains chlorophyll a (~1.69 mg/g DW), chlorophyll b (~0.71 mg/g DW), carotenoids (~5.38 µg/g DW), phenolic compounds (~28.03 mg GAE/g DW), low-molecular-weight antimicrobial peptides (<10 kDa), and tocopherols including α-tocopherol. It also provides vitamins A, B1, B2, B3, and D2, though precise concentrations for all micronutrients in standardized dried biomass have not been fully characterized in published literature.
Is there any clinical evidence that Tetraselmis suecica works as a supplement in humans?
No human clinical trials have been conducted on Tetraselmis suecica as a nutritional supplement or therapeutic agent; all evidence to date is limited to in vitro assays and one aquaculture feeding study. The in vitro antioxidant (DPPH IC50 ~37–38 ppm) and antibacterial data (96% E. coli killing at 0.5 µg/µL) are scientifically interesting but cannot be directly extrapolated to human health outcomes without pharmacokinetic and clinical studies.
What is the antioxidant activity of Tetraselmis suecica compared to other microalgae?
Acetone extracts of T. suecica demonstrate a DPPH radical scavenging IC50 of 37.32–38.26 ppm, which falls below the 50 ppm threshold conventionally classified as 'very strong' antioxidant activity in this assay system. This positions it favorably alongside other antioxidant-rich microalgae such as Haematococcus pluvialis (astaxanthin source) and Spirulina, although direct head-to-head comparisons under identical assay conditions are limited in the literature.
What is the recommended dosage of Tetraselmis suecica for humans?
No established or evidence-based supplemental dose exists for Tetraselmis suecica in humans, as no clinical trials or pharmacokinetic studies have been performed. Research preparations include crude acetone extracts tested in vitro at DPPH IC50 concentrations of ~37–38 ppm and peptide fractions active at 0.5 µg/µL against bacteria; these in vitro concentrations cannot be directly translated into oral dosing recommendations without human absorption and metabolism data.
Is Tetraselmis suecica safe to consume, and are there any known side effects?
The safety of Tetraselmis suecica for human consumption is unestablished, as no toxicology studies, adverse event data, or regulatory approvals for human supplemental use have been published. Potential concerns include heavy metal accumulation (arsenic, cadmium) from marine cultivation water, allergenicity in seafood-sensitive individuals, and the absence of maximum tolerated dose data; individuals who are pregnant, breastfeeding, or taking anticoagulants or antibiotics should avoid use until clinical safety data are available.
Can Tetraselmis suecica peptides be absorbed intact through the digestive system?
Tetraselmis suecica's bioactive peptides are small (<10 kDa), which generally favors absorption, but peptide bioavailability depends on digestive proteolysis and intestinal permeability. Most dietary peptides are broken down into amino acids or dipeptides during digestion, though some small peptides may be transported via specific intestinal transporters. Encapsulation or standardized extract forms may improve peptide stability and delivery compared to whole biomass.
How does Tetraselmis suecica's antibacterial mechanism compare to conventional antimicrobial supplements?
Tetraselmis suecica's antibacterial activity derives from small bioactive peptides and other metabolites extracted via acid and chromatography purification, rather than from essential oils or plant alkaloids common in herbal antimicrobials. Its peptide-based mechanism is distinct from synthetic antibiotics and may offer different resistance profiles, though direct clinical comparisons to other natural antimicrobials are limited. The in vitro antibacterial potency requires verification in human studies to establish functional relevance as an oral supplement.
Are there specific populations that would benefit most from Tetraselmis suecica supplementation?
Individuals seeking high-potency antioxidant and antimicrobial support—such as those with oxidative stress, compromised immune function, or interest in microalga-based nutrition—may be candidates, though robust human efficacy data remain limited. Vegans and vegetarians may value Tetraselmis suecica as a plant-based source of complete protein and micronutrients (including B12 in some strains), though bioavailability verification is needed. Those with shellfish or iodine sensitivities should verify iodine content and potential cross-reactivity before use.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w tetraselmis-suecica-green-microalga curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
